FIGO IIIC/IV期高级别浆液性卵巢癌(HGSOC)患者中化疗反应评分(CRS)与肿瘤同源重组缺陷(tHRD)的关系
Association between chemotherapy response score (CRS) and tumour homologous recombination deficiency (tHRD) in women with newly diagnosed FIGO stage IIIC/IV high-grade serous ovarian cancer(HGSOC)
Authors: Fiona Britton, Cong Zhou, George J. Burghel, Helene Schlecht, Sudha Desai, Bethany Barnes, Andrew R. Clamp, Jurjees Hasan, Claire L. Mitchell, Zena Salih, Richard Edmondson, Gareth D. Evans, Gordon C. Jayson, Stephen Taylor, Robert D. Morgan
审批编号:CN-146554
过期日期:2025-11-6
如有会议直播/学术报道
商务合作/原创投稿等需求
请联系我们
业务合作:段老师 18612983124
原创投稿:fcktougao@126.com
座机号码:010-56291763